MEI Pharma announces a 100 million USD PIPE deal to adopt Litecoin (LTC) as its primary treasury reserve. This is a significant move for a publicly traded biotech firm.
Along with this investment, Litecoin creator Charlie Lee and GSR will join MEI’s board, reflecting confidence in LTC and integrating cryptocurrencies into traditional sectors.
Following the announcement, MEIP stock jumped over 80%, showcasing increased investor interest in crypto’s role in the pharmaceutical industry.
Leave a Reply